Skip to main content

A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer's Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Behavioral Neurology

Awarded By

AbbVie Inc.

Start Date

September 1, 2016

End Date

December 31, 2021
 

Administered By

Neurology, Behavioral Neurology

Awarded By

AbbVie Inc.

Start Date

September 1, 2016

End Date

December 31, 2021